Amikacin Pseudomonas
Amikacin is an antimicrobial with activity against more resistant gram-negative bacilli such as Acinetobacter baumanii and Pseudomonas aeruginosa. It also has excellent activity against most aerobic gram-negative bacilli from the Enterobacteriaceae family,由 WK Lau 著作 · 1977 · 被引用 32 次 — Amikacin is clinically effective in treating Pseudomonas-associated pulmonary infections complicating cystic fibrosis. ,由 D Hocquet 著作 · 2014 · 被引用 22 次 — Metronidazole increases the emergence of ciprofloxacin- and amikacin-resistant Pseudomonas aeruginosa by inducing the SOS response | Journal of ...,由 SM Farhan 著作 · 2021 · 被引用 13 次 — In this study we investigate the in vitro and in vivo effect of amikacin and imipenem combination against resistant P. aeruginosa. ,由 ML Avent 著作 · 2022 · 被引用 9 次 — We studied the extent of bacterial killing by and the emergence of resistance to meropenem and amikacin as monotherapies and as a combination therapy. ,由 X Tang 著作 · 2022 · 被引用 20 次 — The glucose-potentiated amikacin-mediated killing was effective to both lab-evolved PA-R SCF and clinical multidrug-resistant P. aeruginosa. ,由 A Motos 著作 · 2023 · 被引用 6 次 — Nebulized amikacin and fosfomycin for severe pseudomonas aeruginosa pneumonia: an experimental study. Crit Care Med. 2019;47(6):e470–7 ... ,由 H Yang 著作 · 2023 · 被引用 2 次 — Meropenem/amikacin combination resulted in notable perturbations of metabolic pathways essential for survival of P. aeruginosa, whereas monotherapies had ... ,由 M Sato 著作 · 2022 — We report a Case of pneumonia caused by MDRP after allogeneic hematopoietic stem cell transplantation (HSCT) treated with inhaled colistin and amikacin.
| 相關軟體 VMware Workstation Pro 資訊 | |
|---|---|
 Amikacin Pseudomonas 相關參考資料
Amikacin - StatPearls - NCBI Bookshelf
Amikacin is an antimicrobial with activity against more resistant gram-negative bacilli such as Acinetobacter baumanii and Pseudomonas aeruginosa. It also has excellent activity against most aerobic g... https://www.ncbi.nlm.nih.gov Amikacin therapy of exacerbations of Pseudomonas ...
由 WK Lau 著作 · 1977 · 被引用 32 次 — Amikacin is clinically effective in treating Pseudomonas-associated pulmonary infections complicating cystic fibrosis. https://pubmed.ncbi.nlm.nih.go and amikacin-resistant Pseudomonas aeruginosa by inducing ...
由 D Hocquet 著作 · 2014 · 被引用 22 次 — Metronidazole increases the emergence of ciprofloxacin- and amikacin-resistant Pseudomonas aeruginosa by inducing the SOS response | Journal of ... https://academic.oup.com Effect of Imipenem and Amikacin Combination against ...
由 SM Farhan 著作 · 2021 · 被引用 13 次 — In this study we investigate the in vitro and in vivo effect of amikacin and imipenem combination against resistant P. aeruginosa. https://www.mdpi.com Evaluating Mono- and Combination Therapy of Meropenem ...
由 ML Avent 著作 · 2022 · 被引用 9 次 — We studied the extent of bacterial killing by and the emergence of resistance to meropenem and amikacin as monotherapies and as a combination therapy. https://journals.asm.org Glucose-Potentiated Amikacin Killing of Cefoperazone ...
由 X Tang 著作 · 2022 · 被引用 20 次 — The glucose-potentiated amikacin-mediated killing was effective to both lab-evolved PA-R SCF and clinical multidrug-resistant P. aeruginosa. https://www.frontiersin.org Inhaled amikacin for pneumonia treatment and dissemination ...
由 A Motos 著作 · 2023 · 被引用 6 次 — Nebulized amikacin and fosfomycin for severe pseudomonas aeruginosa pneumonia: an experimental study. Crit Care Med. 2019;47(6):e470–7 ... https://ccforum.biomedcentral. Metabolomics reveals the mechanism of action ...
由 H Yang 著作 · 2023 · 被引用 2 次 — Meropenem/amikacin combination resulted in notable perturbations of metabolic pathways essential for survival of P. aeruginosa, whereas monotherapies had ... https://www.frontiersin.org Successful treatment of pneumonia caused by multidrug ...
由 M Sato 著作 · 2022 — We report a Case of pneumonia caused by MDRP after allogeneic hematopoietic stem cell transplantation (HSCT) treated with inhaled colistin and amikacin. https://www.sciencedirect.com |